{"id":41306,"date":"2023-01-24T01:14:53","date_gmt":"2023-01-24T01:14:53","guid":{"rendered":"https:\/\/www.sisinternational.com\/?page_id=41306"},"modified":"2026-05-05T16:45:04","modified_gmt":"2026-05-05T20:45:04","slug":"investigacion-de-mercado-de-turismo-medico","status":"publish","type":"page","link":"https:\/\/www.sisinternational.com\/es\/pericia\/investigacion-de-mercado-de-turismo-medico\/","title":{"rendered":"Medical Tourism Market Research: Corridor Strategy"},"content":{"rendered":"
\n

Investigaci\u00f3n de Mercado de Turismo M\u00e9dico<\/a><\/h1>\n
\"Investigaci\u00f3n<\/figure>\n<\/p>\n

El turismo m\u00e9dico es una industria en crecimiento en todo el mundo debido al aumento de los costos de los tratamientos de salud en los pa\u00edses de origen, la globalizaci\u00f3n de la industria de la salud y el creciente acceso a trabajadores m\u00e9dicos calificados en todo el mundo. Los pa\u00edses de los mercados emergentes est\u00e1n dando prioridad a esta industria para atraer turistas m\u00e9dicos e impulsar las exportaciones de industrias de servicios avanzados, como los sectores sanitario, biotecnol\u00f3gico y farmac\u00e9utico.<\/p>\n

Turismo M\u00e9dico se define como el proceso de viajar fuera del pa\u00eds de residencia para recibir atenci\u00f3n m\u00e9dica. Aunque muchos identifican al turismo m\u00e9dico como personas que viajan desde pa\u00edses ricos a pa\u00edses en desarrollo para recibir atenci\u00f3n m\u00e9dica m\u00e1s barata, el proceso tambi\u00e9n se aplica a la situaci\u00f3n opuesta en la que personas de pa\u00edses menos desarrollados viajan a econom\u00edas ricas para realizar operaciones que no se realizan f\u00e1cilmente en sus pa\u00edses de origen. .<\/p>\n

SIS analiza todas las oportunidades potenciales que trae esta forma de trabajar y c\u00f3mo los clientes y proveedores potenciales pueden prosperar y mejorar los tratamientos.<\/p>\n

About the Medical Tourism Market<\/a><\/h2>\n

El Turismo M\u00e9dico est\u00e1 presente en casi todos los pa\u00edses del mundo. Por ejemplo, los residentes estadounidenses viajan a M\u00e9xico, Canad\u00e1 o los pa\u00edses de Am\u00e9rica Central y del Sur para obtener atenci\u00f3n m\u00e9dica m\u00e1s barata, mientras que los europeos viajan fuera de la UE o entre pa\u00edses donde los precios son m\u00e1s bajos.<\/p>\n

Algunos de los destinos m\u00e1s populares son Cuba, Grecia, Tailandia, Corea y Serbia porque sus m\u00e9dicos y especialistas se encuentran entre los mejores del mundo.<\/p>\n

Las razones m\u00e1s comunes por las que las personas viajan a otro pa\u00eds para recibir atenci\u00f3n m\u00e9dica son:<\/p>\n

    \n
  1. Precio (muchas personas viajan a otros pa\u00edses porque no pueden pagar un seguro m\u00e9dico por su cuenta o porque los costos del procedimiento est\u00e1n muy por encima de su presupuesto, por lo que podemos concluir que este es el principal motivo del turismo m\u00e9dico)<\/li>\n
  2. La legalidad del servicio (algunos servicios de salud como el aborto o la eutanasia est\u00e1n prohibidos por ley en algunos pa\u00edses, pero no en todos)
    Diferencias culturales (muchos inmigrantes quieren ser tratados en su pa\u00eds de origen debido a sus creencias religiosas)<\/li>\n
  3. Acceso a procedimientos experimentales.<\/li>\n
  4. Acceso a una atenci\u00f3n de mayor calidad<\/li>\n<\/ol>\n

    Entre los procedimientos que las personas deciden ir a otro pa\u00eds se encuentran (pero no se limitan a): tratamientos de fertilidad (por ejemplo, gestaci\u00f3n subrogada, FIV y tecnolog\u00edas de reproducci\u00f3n asistida), trasplantes de \u00f3rganos, cirug\u00eda pl\u00e1stica, atenci\u00f3n dental y tratamientos experimentales contra el c\u00e1ncer.<\/p>\n

    Investigaci\u00f3n de mercado del recorrido del cliente<\/a> can uncover numerous sources of competitive advantage in the Medical Tourism sector. Customers face numerous benefits and risks in medical tourism and the stakes can be high. Before patients decide to have their procedure done in a foreign country, they often conduct comprehensive in-person and online research to pick the right facility, treatment and medical provider for his or her needs. As these decisions can be outside their domestic medical establishments, the online research that patients conduct is important in their decision making. Furthermore, people who opt for medical tourism often exhaust all available medical treatment options in their home country so they can be a vulnerable group requiring information about benefits and risks. Market Research provides the insight for Medical<\/a> Tourism providers to better serve potential patients.<\/p>\n

    Las complicaciones m\u00e1s comunes del turismo m\u00e9dico incluyen:<\/p>\n

      \n
    1. Enfermedades y riesgo de infecciones: desde complicaciones de procedimientos (heridas o infecciones derivadas de donantes) hasta enfermedades infecciosas si una persona viaja a pa\u00edses lejanos.<\/li>\n
    2. Resistencia a los antibi\u00f3ticos: este es un riesgo relativamente raro, pero todo turista m\u00e9dico debe ser consciente de ello.<\/li>\n
    3. Problemas con la comunicaci\u00f3n: solo los centros registrados pueden proporcionar al personal conocimientos avanzados del idioma ingl\u00e9s o del idioma nativo del paciente, lo cual es esencial para una atenci\u00f3n adecuada.<\/li>\n
    4. Viajes a\u00e9reos: si los pacientes vuelan inmediatamente despu\u00e9s de la cirug\u00eda, corren un alto riesgo de sufrir co\u00e1gulos sangu\u00edneos u otros riesgos de viaje, por lo que es aconsejable esperar al menos entre 10 y 14 d\u00edas antes de regresar a casa.<\/li>\n<\/ol>\n<\/div>\n

      Medical Investigaci\u00f3n de Mercado Tur\u00edstico<\/a>: How Leading Operators Build Cross-Border Patient Pipelines<\/h1>\n

      Medical tourism market research has shifted from descriptive country profiling to operational intelligence that informs corridor selection, payer partnerships, and clinical specialty positioning. The sophisticated buyers in this category, hospital networks, sovereign health funds, insurer-employer coalitions, and private equity-backed specialty groups, treat patient flow modeling the way airlines treat route economics.<\/p>\n

      The global cross-border patient market spans elective orthopedics, oncology second opinions, fertility, dental, cardiac, and bariatric procedures. Each travels along distinct corridors with distinct economics. Mexico-US dental and bariatric flows behave nothing like Gulf-to-Germany oncology referrals or China-to-Japan precision medicine cases. Treating them as a single market produces unusable forecasts.<\/p>\n

      Why Corridor-Level Medical Tourism Market Research Outperforms Country Reports<\/h2>\n

      Country-level sizing obscures the unit of competition. Patients do not choose Thailand. They choose a specific Bangkok hospital with JCI accreditation, a named surgeon, an English-speaking concierge, and a payer arrangement that covers travel. Corridor analysis isolates origin-destination pairs and decomposes them into procedure mix, payer source, facilitator margin, and length-of-stay economics.<\/p>\n

      The leading operators model corridors the way logistics firms model lanes. Singapore-Indonesia cardiac. Turkey-UK hair restoration and dental. Costa Rica-US dental and orthopedics. Korea-China aesthetic surgery. India-East Africa oncology. Each corridor has a distinct conversion funnel from inquiry to deposit to arrival to follow-up, and the leakage points differ.<\/p>\n

      <\/p>\n

      According to SIS International Research, the operators winning share in mature corridors invest heavily in pre-arrival clinical triage, often a structured remote consultation that qualifies the patient and pre-builds the care plan.<\/span> This single step compresses on-site length of stay, reduces clinical surprises, and lifts deposit-to-arrival conversion materially above facilitator-led alternatives.<\/p>\n

      <\/span><\/p>\n

      The Five Forces Reshaping Cross-Border Patient Flows<\/h2>\n

      Five structural forces govern where the next decade of growth concentrates. Each is measurable and each rewards firms that build proprietary intelligence rather than rely on syndicated reports.<\/p>\n

      Payer integration.<\/strong> Self-funded US employers, UK NHS overflow contracting, and Gulf state-sponsored programs have moved from pilot to procurement. The buyer is no longer the patient. It is a benefits committee or a sovereign health authority running an RFP with bundled-price expectations and outcomes reporting requirements.<\/p>\n

      Accreditation as table stakes.<\/strong> JCI, Temos, and ISO 9001 certifications no longer differentiate. The differentiator is publishing risk-adjusted outcomes by surgeon and procedure, the standard set by Bumrungrad, Anadolu Medical Center, and Apollo Hospitals.<\/p>\n

      Facilitator disintermediation.<\/strong> Hospitals with mature international patient departments, Gleneagles, Asan Medical Center, Hospital Israelita Albert Einstein, are building direct payer relationships and bypassing traditional facilitators on high-margin cases.<\/p>\n

      Telemedicine pre-screening.<\/strong> Remote second opinions have become the top of the funnel. The hospital that captures the second opinion captures a disproportionate share of conversions.<\/p>\n

      Visa, currency, and geopolitical friction.<\/strong> Corridor economics shift quickly with visa policy and exchange rates. Turkey’s lira depreciation rebuilt its dental and aesthetic corridors within two years. Sanctions and travel restrictions can collapse a corridor in a quarter.<\/p>\n

      What Sophisticated Medical Tourism Market Research Actually Measures<\/h2>\n

      Descriptive market sizing is the entry-level deliverable. The intelligence that informs capital allocation goes deeper.<\/p>\n

      \n\n\n\n\n\n\n\n\n\n
      Research Layer<\/th>\nWhat It Measures<\/th>\nDecision It Informs<\/th>\n<\/tr>\n<\/thead>\n
      Corridor sizing<\/td>\nProcedure-level patient volumes by origin-destination pair<\/td>\nMarket entry, capacity planning<\/td>\n<\/tr>\n
      Payer mapping<\/td>\nSelf-pay vs employer-funded vs sovereign-sponsored mix<\/td>\nChannel investment, pricing<\/td>\n<\/tr>\n
      Facilitator economics<\/td>\nCommission structures, lead quality, conversion rates<\/td>\nDirect vs intermediated channel mix<\/td>\n<\/tr>\n
      Clinical outcomes benchmarking<\/td>\nRisk-adjusted complication and revision rates<\/td>\nSpecialty positioning, payer contracting<\/td>\n<\/tr>\n
      Patient journey ethnography<\/td>\nDecision triggers, anxiety points, post-op follow-up gaps<\/td>\nService design, retention<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

      Source: SIS International Research<\/em><\/p>\n

      The patient journey layer is where most market entry decks are weakest. Cross-border patients make decisions across an eight-to-fourteen-week window with multiple household stakeholders, and the conversion-killing moments are rarely clinical. They are visa anxiety, deposit refund policy ambiguity, and post-arrival communication gaps.<\/p>\n

      The SIS Approach to Medical Tourism Market Research<\/h2>\n

      <\/p>\n

      SIS International’s healthcare practice combines structured B2B expert interviews with international patient department directors, ethnographic research with returning patients, and competitive intelligence on hospital pricing, accreditation, and outcomes disclosure. A recent mixed-methodology engagement targeted 200 respondents across Brazil to map inbound and outbound patient flows for a Fortune 500 healthcare client evaluating Latin American corridor expansion.<\/p>\n

      <\/span><\/p>\n

      The healthcare practice has fielded patient-side and provider-side studies across China, Mexico, the United States, Germany, Korea, Singapore, and Israel, including direct CEO-level interviews with overseas medical services agencies serving outbound Chinese patients. This dual-perspective design, capturing both the originating facilitator and the receiving hospital, surfaces the pricing and commission realities that single-sided studies miss.<\/p>\n

      SIS Corridor Viability Framework<\/h3>\n

      Four dimensions determine whether a corridor merits investment.<\/p>\n